Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 1
2021 2
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Structure-Based Design, Synthesis, and Biological Evaluation of the Cage-Amide Derived Orthopox Virus Replication Inhibitors.
Mozhaitsev ES, Suslov EV, Rastrepaeva DA, Yarovaya OI, Borisevich SS, Khamitov EM, Kolybalov DS, Arkhipov SG, Bormotov NI, Shishkina LN, Serova OA, Brunilin RV, Vernigora AA, Nawrozkij MB, Agafonov AP, Maksyutov RA, Volcho KP, Salakhutdinov NF. Mozhaitsev ES, et al. Among authors: serova oa. Viruses. 2022 Dec 21;15(1):29. doi: 10.3390/v15010029. Viruses. 2022. PMID: 36680072 Free PMC article.
Design, Synthesis, and Biological Evaluation of (+)-Camphor- and (-)-Fenchone-Based Derivatives as Potent Orthopoxvirus Inhibitors.
Sokolova AS, Kovaleva KS, Kuranov SO, Bormotov NI, Borisevich SS, Zhukovets AA, Yarovaya OI, Serova OA, Nawrozkij MB, Vernigora AA, Davidenko AV, Khamitov EM, Peshkov RY, Shishkina LN, Maksuytov RA, Salakhutdinov NF. Sokolova AS, et al. Among authors: serova oa. ChemMedChem. 2022 Jun 20;17(12):e202100771. doi: 10.1002/cmdc.202100771. Epub 2022 Apr 22. ChemMedChem. 2022. PMID: 35388614
(+)-Camphor and (-)-borneol derivatives as potential anti-orthopoxvirus agents.
Sokolova AS, Kovaleva KS, Yarovaya OI, Bormotov NI, Shishkina LN, Serova OA, Sergeev AA, Agafonov AP, Maksuytov RA, Salakhutdinov NF. Sokolova AS, et al. Among authors: serova oa. Arch Pharm (Weinheim). 2021 Jun;354(6):e2100038. doi: 10.1002/ardp.202100038. Epub 2021 Feb 19. Arch Pharm (Weinheim). 2021. PMID: 33605479
Safety and Pharmacokinetics of the Substance of the Anti-Smallpox Drug NIOCH-14 after Oral Administration to Laboratory Animals.
Shishkina LN, Mazurkov OY, Bormotov NI, Skarnovich MO, Serova OA, Mazurkova NA, Skarnovich MA, Chernonosov AA, Selivanov BA, Tikhonov AY, Gamaley SG, Shimina GG, Sysoyeva GM, Taranov OS, Danilenko ED, Agafonov AP, Maksyutov RA. Shishkina LN, et al. Among authors: serova oa. Viruses. 2023 Jan 11;15(1):205. doi: 10.3390/v15010205. Viruses. 2023. PMID: 36680245 Free PMC article.
Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels.
Shiryaev VA, Radchenko EV, Palyulin VA, Zefirov NS, Bormotov NI, Serova OA, Shishkina LN, Baimuratov MR, Bormasheva KM, Gruzd YA, Ivleva EA, Leonova MV, Lukashenko AV, Osipov DV, Osyanin VA, Reznikov AN, Shadrikova VA, Sibiryakova AE, Tkachenko IM, Klimochkin YN. Shiryaev VA, et al. Among authors: serova oa. Eur J Med Chem. 2018 Oct 5;158:214-235. doi: 10.1016/j.ejmech.2018.08.009. Epub 2018 Aug 6. Eur J Med Chem. 2018. PMID: 30218908
Adamantane derivatives as potential inhibitors of p37 major envelope protein and poxvirus reproduction. Design, synthesis and antiviral activity.
Shiryaev VA, Skomorohov MY, Leonova MV, Bormotov NI, Serova OA, Shishkina LN, Agafonov AP, Maksyutov RA, Klimochkin YN. Shiryaev VA, et al. Among authors: serova oa. Eur J Med Chem. 2021 Oct 5;221:113485. doi: 10.1016/j.ejmech.2021.113485. Epub 2021 Apr 29. Eur J Med Chem. 2021. PMID: 33965861 Free PMC article.